Add like
Add dislike
Add to saved papers

Potential cost savings of MR imaging obtained before arthroscopy of the knee: evaluation of 50 consecutive patients.

OBJECTIVE: We attempted to determine the potential cost savings of prearthroscopic knee MR imaging examinations.

SUBJECTS AND METHODS: This prospective study involved 50 consecutive patients. The patients met the surgical-indications-for-monitoring-appropriateness criteria for knee arthroscopy and underwent MR imaging of the knee before arthroscopy. For all patients, we compared MR imaging and arthroscopic findings. On the basis of a cost of $1000 for each MR imaging examination and $4000 for each diagnostic arthroscopy, we decided that cost-effective MR imaging would require 25% true negativity.

RESULTS: The respective sensitivities and specificities of MR imaging of the knee were 100% and 90% for revealing anterior cruciate ligament interruption, 100% and 84% for revealing posterior cruciate ligament tears, 90% and 97% for revealing medial meniscal tears, 60% and 100% for revealing lateral meniscal tears, and 94% and 93% for revealing composite injury (one or more of these abnormalities). With MR imaging examinations obtained before surgery, we found 21 (42%) of 50 arthroscopies to be unnecessary.

CONCLUSION: Despite stringent clinical criteria used in selecting patients for arthroscopy, 42% of our patients could have been spared surgery on the basis of the anatomy revealed by MR imaging. Our study indicates that MR imaging obtained before arthroscopy of the knee can produce a savings of as much as $680 per MR imaging examination performed on the knee.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app